Periodic Presumptive Treatment vs. doxyPEP for STI Control in Kenyan MSM — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Periodic Presumptive Treatment vs. doxyPEP for STI Control in Kenyan MSM — Stella

Recruiting

Back to Gonorrhea Male trials

Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.

Trial locations(3 sites)

Kenya

Anza Mapema Clinic, Kisumu

University of Washington/Pwani Research Centre at the Ganjoni Municipal Clinic, Mombasa, Mombasa

TRANSFORM Clinic, Nairobi

Key details

Phase

Post-approval study

Sponsor

University of Washington

Collaborators

Aurum Institute, Nyanza Reproductive Health Society

Enrollment target

~2,900 participants

Started

October 2025

Primary completion

October 2028

Age range

18 Years – 29 Years

Sex

Male only

Last updated November 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov